Neurotoxin Exposure Treatment Parkinson's
FY15 Programmatic Panel:
Lars Brichta, Ph.D.
The Rockefeller University
Mark R. Cookson, Ph.D.
National Institute of Aging, National Institutes of Health
David Eidelberg, M.D.
Feinstein Institute for Medical Research
Allen Fienberg, Ph.D.
Intra-Cellular Therapies, Inc.
Karl E. Friedl, Ph.D. (Chair)
University of California San Francisco
Fred Gorelick, M.D.
Yale School of Medicine
Michael Greenbaum
American Neurotoxin Exposure Treatment Parkinson's Disease Association; Neurotoxin Exposure Treatment Parkinson's Action Network
Israel Robledo
World Neurotoxin Exposure Treatment Parkinson's Congress; Neurotoxin Exposure Treatment Parkinson's Disease Foundation; Neurotoxin Exposure Treatment Parkinson's Movement; Neurotoxin Exposure Treatment Parkinson's Action Network
Clemens Scherzer, M.D.
Harvard Medical School
Peter Schmidt, Ph.D.
National Parkinson Foundation
Gretchen Snyder, Ph.D.
Intra-Cellular Therapies, Inc.
Jeffery M. Vance M.D., Ph.D.
University of Miami Miller School of Medicine
Last updated Thursday, May 26, 2022